key: cord-0065003-o27kyqk2 authors: Benatia, David; Godefroy, Raphael; Lewis, Joshua title: Estimates of COVID-19 Cases across Four Canadian Provinces date: 2020-10-07 journal: nan DOI: 10.3138/cpp.2020-035 sha: 929ccf81ff269ac70cdf091aae0e58b146a13eb1 doc_id: 65003 cord_uid: o27kyqk2 This article estimates population infection rates from coronavirus disease 2019 (COVID-19) across four Canadian provinces from late March to early May 2020. The analysis combines daily data on the number of conducted tests and diagnosed cases with a methodology that corrects for non-random testing. We estimate the relationship between daily changes in the number of conducted tests and the fraction of positive cases in the non-random sample (typically less than 1 percent of the population) and apply this gradient to extrapolate the predicted fraction of positive cases if testing were expanded to the entire population. Over the sample period, the estimated population infection rates were 1.7–2.6 percent in Quebec, 0.7–1.4 percent in Ontario, 0.5–1.2 percent in Alberta, and 0.2–0.4 percent in British Columbia. In each province, these estimates are substantially below the average positive case rate, consistent with non-random testing of higher-risk populations. The results also imply widespread undiagnosed COVID-19 infection. For each identified case by mid-April, we estimate there were roughly 12 population infections. The fi rst cases of coronavirus disease 2019 in Canada were documented in late January 2020, and by Average population infection rates over the sample period ranged from 0.3 percent in British Columbia to 3.0 percent in Quebec. Infection rates in British Columbia declined modestly over the sample period. In Ontario, infection rates rose from early to mid-April and subsequently declined. Meanwhile, Quebec and Alberta experienced increases in population infection rates over the month of April. These trends need not refl ect increases in the number of newly infected individuals because our population infection rates capture both newly infected individuals and those with continued detectable viral load over the sample period. 3 Our results also suggest widespread undetected COVID-19 infection across Canadian provinces. We calculate that for every diagnosed case, there were 12 population infections in mid-April. The ratio of population infection to diagnosis ranges from 8.6 in British Columbia to 14.8 in Ontario. These estimates are comparable to recent evidence on the rates of undetected infection in the United States and internationally ( Ferguson et al. 2020 ; Johndrow, Lum, and Ball 2020 ; Perkins et al. 2020 ; Verity et al. 2020 ) . For example, Aspelund et al. (2020 ) estimate that 80-90 percent of COVID-19 cases went undiagnosed in Iceland from late March to early April. Benatia et al. (2020 ) estimate a ratio of 12 population infections per diagnosed case in the United States by early April. More recently, the CDC (2020 a) reported results based on seroprevalence that suggest that total infections were 10 times higher than the number of confi rmed cases. This article provides new evidence on overall population infection rates for COVID-19 in Canada. Our fi ndings complement evidence for COVID-19 prevalence nationwide. Using survey results for COVID-19 symptoms, Reid (2020 ) fi nds that more than 100,000 households reported COVID-like symptoms after adjusting for seasonal infl uenza rates. The results do not account for potentially large numbers of asymptomatic infections. Meanwhile, Verity et al. (2020 ) combines assumptions regarding the age-adjusted case fatality rate with COVID-related deaths to estimate total population infections in Canada on 31 March. These estimates indicate that the case detection rate was just 5 percent through March. Our analysis provides the fi rst provincial-level estimates. Given wide cross-province differences in per capita testing, offi cial case counts may mask important geographic differences in the severity of the outbreak. Indeed, whereas the offi cial case count in Quebec was 55 percent higher than in Ontario, our results show that gap in total cases was less than 20 percent. Our empirical framework complements existing methods used to estimate population infection rates in the United States and internationally ( Ferguson et al. 2020 ; Javan, Fox, and Meyers 2020 ; Johndrow et al. 2020 ; Li, Pei, et al. 2020 ; Perkins et al. 2020 ; Verity et al. 2020 ) . One approach has been no symptoms may not seek testing, however, the potential exists for widespread undocumented infections (see Bai et al. 2020 ; Dong et al. 2020 ; Hoehl et al. 2020 ; Lu et al. 2020 ; Pan et al. 2020 ) . In this article, we estimate population infection rates for COVID-19 across four Canadian provinces-Quebec, Ontario, Alberta, and British Columbia-from late March to early May. The analysis is based on the methodology developed in Benatia, Godefroy, and Lewis (2020 ) that corrects observed infection rates among tested individuals for non-random sampling to calculate infection rates in the overall population. 1 To implement the procedure, we estimate the relationship between the number of tests and the share of positive tests. This gradient is informative for the severity of selection bias. For example, a negative slope indicates positive selection bias, because individuals who are most frequently tested have the highest probability of infection. If the functional form of this relationship can be consistently estimated, we can compute the population infection rate as a combination of the observed sample infection rate and the estimated selection gradient, which corrects for non-random testing. In practice, our approach faces two main empirical challenges. First, there is concern that the supply of testing may respond endogenously to underlying disease prevalence. For example, if policy-makers expand testing in response to increases in underlying disease prevalence, our estimation strategy would underestimate the selection bias gradient and thus overestimate total population infections. To address this concern, we focus on high-frequency day-to-day changes in the number of completed tests across US states and all Canadian provinces. 2 Because there is little scope for evolution in disease prevalence from one day to the next, daily changes in testing should be orthogonal to changes in population infection rates. To further validate this assumption, we estimate models that control for province and state fi xed effects, thereby allowing for daily exponential growth in disease prevalence that is specifi c to each jurisdiction. The second empirical challenge stems from uncertainty regarding the true functional relationship between the positive test rate and the size of the tested sample. In the empirical implementation, we specify a fl exible functional relationship that appears to fi t the data well. Nevertheless, the results ultimately depend on an untested assumption that the estimated relationship-based on data from the sample of tested individuals who typically make up less than 1 percent of the population-can be extrapolated to the rest of the population. Despite this limitation, we believe the approach offers signifi cant advantages over existing methods used to estimate population infection rates (described later). In ongoing work, we hope to refi ne the estimation procedure to address this functional form concern. We find wide cross-province differences in both the level of population infection rates and their trends. reporting standards and days on which provincial health authorities did not release information on completed tests. 4 In addition, we use information on the number of positive tests by age group, which is available from provincial health departments, and provincial population estimates from Statistics Canada (2020 ). We supplement these data with information on total test results and positive cases across US states for the same time period from the COVID Tracking Project, a site launched by journalists from The Atlantic that publishes high-quality data on the outbreak across US states ( Meyer, Kissane, and Madrigal 2020 ) . Figure 1 reports the daily tests and positive cases across the four provinces. Daily testing was fairly stable in Quebec throughout April. In contrast, daily testing substantially increased in both Ontario and Alberta and to a lesser extent in British Columbia. In this section, we present the theoretical framework developed in Benatia et al. (2020 ) to estimate COVID-19 prevalence. This framework motivates estimating Equation (6). To evaluate population disease prevalence, we develop a simple selection model for COVID-19 testing and use the framework to link observed rates of positive tests to population disease prevalence. We consider a stable population, normalized to a population of one, and denote A and B as the number of sick and healthy individuals, respectively. Let p n denote the probability that a sick person is tested and q n the probability that a healthy person is tested, given a total number of tests, n . Thus, we have n = p n A + q n B, and assuming the test is accurate, the number of positive tests is s = p n A . This simple framework highlights how non-random testing will bias estimates of the population disease prevalence. Using Bayes's rule, we can write the relative probability of testing as which is equal to one if tests are randomly allocated, Pr ( sick ested,n ) = Pr ( sick ). When testing is targeted to individuals who are more likely to be sick, we have Pr ( sick ested,n ) > Pr ( sick ), Pr ( sick ested,n ) > Pr ( sick ), and Pr ( healthy ested,n ) < Pr ( healthy ), so the ratio will be greater than one. In this scenario, the ratio of sick to healthy people in the sample, p n A/q n B , will exceed the ratio in the overall population, A/B . We assume that the severity of selection bias can be expressed as a function of the number of tests, p q f n n n ; , based on the Susceptible Infectious Removed epidemiological model, which calibrates parameters to the specifi c characteristics of the severe acute respiratory syndrome coronavirus 2 pandemic to estimate current and future infections. A challenge for this approach is the large uncertainty regarding the relevant parameter values for the virus and the fact that the parameter values will evolve as societies take different measures to reduce transmission. Other research has relied on Bayesian modelling to infer past disease prevalence from observed COVID-19 deaths. Although these models require fewer assumptions regarding the underlying parameter values, because they scale up observed deaths to estimate population infections, small differences in the assumed case fatality will have substantial effects on the estimates. Given considerable uncertainty regarding the true case fatality, which may depend on local sociodemographic and environmental conditions, and the fact that COVID-19-related deaths may be undercounted during the course of the pandemic, these estimates may not capture the overall extent of population infection (see Severnini 2018 , 2019 ; Clay et al. 2020 ; Han et al. 2020 ; Katz and Sanger-Katz 2020 ; Prakash and Hall 2020 ; Riou, Hauser, Counotte, Margossian, et al. 2020 ; Wu et al. 2020 ) . Most closely related to our article is Manski and Molinari (forthcoming ), who use data on the total number of tests and the positive test rate to estimate ranges for population COVID-19 infection rates for Illinois, New York, and Italy in early April. Their approach requires only the imposition of weak monotonicity assumptions for identifi cation. Their estimated bounds for infection rates are 0.1%-51.7% for Illinois, 0.8%-64.5% for New York, and 0.3%-51.0% for Italy. These are wide, model-free bounds. In this article, we estimate much narrower intervals, which are conditional on the accuracy of our model. Although we have developed our method for use during this crisis to employ the available information as fully as possible, policy-makers should be aware that bounds that include model uncertainty would be wider than ours by some unknown amount, which is not uncommon in econometric analyses. The model-free bounds of Manski and Molinari (forthcoming ) serve as a remind of that issue. Our analysis draws on daily data on total test results (positive plus negative) and positive tests across Canadian provinces and US states for the period 31 March-5 May. Provincial data were obtained from the Epidemiological Data from the COVID-19 Outbreak in Canada project ( Berry et al. 2020 ). This project is conducted by a team of researchers from the Universities of Toronto and Guelph and provides information on cases and testing across provinces based on publicly available information from government reports and news media. We exclude days on which there were identifi ed changes in provincial Notes: This fi gure reports the total daily coronavirus tests and the number of new cases per 100,000 population by province. The trends are based on data from Berry et al. (2020 ) . We exclude days for which there were identifi ed changes in provincial reporting standards and days for which provincial health authorities did not release information on completed tests. Source: Berry et al. (2020 ) and Statistics Canada (2020 ). where n is number of conducted tests and θ is a vector of parameters to be estimated. According to this setup, we can write the fraction of positive tests, s/n, as follows: Taking logs and using the fact that the latter term in the denominator is much larger than one, we can make the following approximation: ( Equation (3) shows that the log share of positive tests in the sample can be approximated by the sum of the log ratio of the relative probability of testing, p n /q n , and the unobserved log ratio of sick to healthy people in the population, A/B . To conduct the estimation, we adopt a fi rst difference estimator, using as the dependent variable the difference To implement the procedure described in the preceding section, we specify the following functional form for the selection process into testing, f ( n;θ ): p q f n e n n n ; 1 . The term e γ + β n ≥ 0 refl ects the fact that testing has been targeted toward higher-risk populations, with the intercept, γ , capturing the severity of selection bias when testing is limited. Meanwhile, the coeffi cient β < 0 identifi es how selection bias decreases with n as the ratio p n /q n approaches one. Intuitively, as testing expands, the sample will become more representative of the overall population, and the selection bias will diminish. We substitute this function into the fi rst difference regression model, taking a third-order power series approximation of the log function, which yields the following estimating equation We estimate Equation (6) by non-linear least squares, allowing for heteroskedastic errors. 7 After estimation, we derive predicted values for population infection rates based on Equation (5), using the delta method to construct confi dence intervals. Before turning to the main results, several caveats should be highlighted. First, the estimates of population infection rates depend on a correctly specifi ed functional relationship between the positive test rate and the size of the tested sample. 8 Although the model fi ts the data well (see Figure 2 ), an important assumption underlying our analysis is that this observed relationship in the tested sample-who typically make up less than 1 percent of the population-would continue to hold if testing were expanded out to the broader population. The accuracy of this extrapolation depends on a smoothness condition on the functional form and may be violated if, for example, some segments of the population can easily be tested and others cannot. We also constrain the population coeffi cients ( α i ,β ) to be the same across jurisdictions. This assumption requires that decisions regarding how to prioritize tests were made similarly across provinces and US states. Although states had latitude to implement their own diagnostic testing procedures, the guidance laid out for testing prioritization by the CDC (2020 b) was broadly similar to the policies implemented across Canadian provincial health departments. We also estimate the model for three distinct . ( 6 ) is a mean zero error term that depends on the change in ratio of sick to healthy individuals in the population from t -1 to t and an idiosyncratic component, ε i,t . Equation (4) forms the basis of our empirical analysis. Our identifying assumption is strict exogeneity in the error term: E ( u i,t i,t ,n i,t-1 ). This assumption ensures that the errors are uncorrelated with any function of changes in the number of tests, ∆ n i,t , and will be violated if changes in the population infection rate were systematically related to testing capacity. This assumption is supported by the short time interval in the daily fi rst difference specifi cation, which limits the scope for disease evolution. Also, in robustness tests, we control for province and state fi xed effects, which allow for jurisdiction-specifi c exponential growth in underlying disease prevalence from one day to the next. These controls do not affect the main coeffi cient estimates. Notice that by focusing on a daily fi rst difference estimator, we are able to partial out the unobserved log ratio of sick to healthy people in the population, A i,t /B i,t . As a result, changes in the share of positive tests depend on the number of tests only through a selection channel. How does this assumption enable us to estimate population infection rates? Using day-to-day changes in the share of positive tests and day-to-day changes in the number of tests, we can recover ( ) as the predicted fraction of positive tests if the entire population in province i was tested on date t, that is, n i,t = pop i . We can rewrite the fi rst difference Equation (4) That is, the predicted log fraction of positive tests in the population is equal to the log fraction of positive tests in the sample plus an adjustment factor that corrects for non-random testing. One could also view our exercise as a reduced form estimation of the relationship between the fraction of individuals who test positive and the size of the tested population (holding constant the population share of those who are sick). Once this relationship has been consistently estimated, we can predict the share of positive tests for any value of n, including when n = pop i . θ θ  ). Consistent with the theoretical framework, we fi nd large estimates of β ranging from -1,093 to -1,391, which implies that the sample selection in testing approaches zero as the number of tests approaches the total population size. We also fi nd alternating signs on coeffi cient 1 2 3,, , consistent with the estimates of the power series approximation developed in Benatia et al. (2020 ) . Figure 2 presents scatterplots of the relationship between daily changes in per capita testing and the share of positive tests across states and provinces for the three time periods. The downward-sloping relationships imply that one-week intervals, 31 March-7 April 7, 14-21 April, and 28 April-5 May, to allow for the possibility that decisions about how to allocate tests across the population may have changed from late March to early May. Because policy decisions regarding testing of elderly populations may have differed across jurisdictions, we also report estimates based solely on cases among individuals aged younger than 70. Finally, our analysis depends on the quality of diagnostic testing, and systematic false-negative test results may affect the population disease prevalence estimates ( Ai et al. 2020 ; Liu et al. 2020 ; Yang et al. 2020 ) . Because our analysis focuses on day-to-day variation, however, changes in the rates of misdiagnosis should not be systematically related to changes in the number of implemented tests. 9 As a result, these errors should not bias the coeffi cient estimates, but they may reduce precision through classical measurement error ( Wooldridge 2002 ) . α α α Notes: This fi gure reports the relationship between daily changes in the exponential of per capita testing and daily changes in the log share of positive tests for the three time periods. The relationship in each period is obtained using the estimated coeffi cient of  from the main estimates of Equation (6). See Table 1 , Columns (1), (3), and (5). Source: Authors' calculations. TN TN TN TN TN TN TN TN TX TX TX TX TX TX TX TX SD SD SD TN TN TN TN TN TN TN TN TX TX TX TX TX TX TX TX larger day-to-day increases in the number of conducted tests are associated with decreases in the share of positive tests. A symptom of selection bias is that variables that have no structural relationship with the dependent variable may appear to be signifi cant ( Heckman 1979 ) . So, these patterns strongly suggest non-random testing, because daily changes in testing should be unrelated to population disease prevalence except through a selection channel. Table 2 reports the results for Quebec, Ontario, Alberta, and British Columbia that adjust observed COVID-19 case rates for non-random testing on the basis of the procedure described in the Methodology section. Column (2) reports the estimates for all-age population infection rates on 4 April, 18 April, and 2 May, along with heteroskedasticity robust 95 percent confi dence intervals. Column (4) reports the average estimates for the three time periods 31 March-4 April, 14-18 April, and 28 April-2 May. These Notes: Column (1) reports the fraction of positive tests on the relevant day. Columns (2)-(3) report the coeffi cient estimates for population prevalence of COVID-19 based on the methodology described in the Methodology section. Heteroskedasticity robust 95% confi dence intervals are reported in parentheses. We report the results for all age prevalence and prevalence among individuals aged younger than 70 y. Columns (4)-(5) report the average estimates for population prevalence of COVID-19 for the three time periods. COVID-19 = coronavirus disease 2019. Source: Authors' calculations. latter averages mitigate sampling error in the daily prevalence estimates, which depend on the observed share of positive tests on any particular day. The results reveal widespread disparities in COVID-19 prevalence across provinces. Population infection rates range from more than 2.2 percent in Quebec to less than 0.4 percent in British Columbia Trends in infection rates differed signifi cantly across provinces. Infection rates in British Columbia declined modestly over the sample period. In Ontario, infection rates rose from early to mid-April and subsequently declined. Meanwhile, Quebec and Alberta experienced steady increases in population infection rates over the sample period. Columns (3) and (5) report the estimated population infection rates among individuals aged younger than 70 years. 10 These estimates will not be infl uenced by specifi c policies regarding the testing of the elderly population and residents of senior residential facilities that may have differed across provinces. 11 The results for Alberta and British Columbia are similar to the overall population prevalence. Meanwhile, the estimates are systematically lower in Ontario and Quebec, particularly in the latter number of diagnosed cases in each province. We multiply the average estimated prevalence from 14-18 April ( Table 2 , Panel B, Column [4] ) by the total province population and compare it with the cumulative diagnosed cases by 23 April. The gap in the two periods captures the typical fi ve-day incubation period to account for the fact that individuals may not seek testing until symptom onset ( Lauer et al. 2020 ; Li, Guan, et al. 2020 ) . In principal, these numbers capture two distinct measures of COVID-19 spread: current infections versus cumulative infections. Nevertheless, given limited COVID-19 infection before mid-March and the fact that viral presence is detectable by PCR testing three weeks after initial symptom onset ( Cai et al. forthcoming ; Zhou et al. 2020 ), population infection rates in mid-April are likely to be similar to cumulative infections since onset. Table 4 presents the results. We fi nd widespread undetected population infection. By 23 April, 41,371 cases had been identifi ed across the four provinces; however, our estimates suggest that there were more than a half million infected individuals. In Quebec and Alberta, we fi nd periods. These results are consistent with the timing of the shift in testing in elderly facilities in these two provinces ( Hinkson and Stevenson 2020 ; Jones 2020 ) . Table 3 explores the robustness of the main estimates to controls for province and state fi xed effects. These controls allow for growth rates in underlying disease prevalence that are specifi c to each locality, to account for the fact that the true infection rate may evolve even within a 24hour period. Because the intercepts are allowed to differ across each jurisdiction, they also account for variation in the daily evolution of the disease across states and provinces as a result of differing enforcement of social distancing or other location-based determinants of disease spread. The results (reported in the even-numbered columns) are virtually identical to the baseline estimates. Moreover, the augmented model tends to produce more precise confi dence intervals, although as noted earlier we emphasize that these confi dence intervals are conditional on our model. To interpret the fi ndings, we calculate the total population infections in mid-April and compare them with the limited in British Columbia, allowing offi cials to better identify clusters of cases. This article provides new evidence on the population prevalence of COVID-19 in Quebec, Ontario, Alberta, and British Columbia from late March to early May. Our analysis adapts a sample selection model approach developed in Benatia et al. (2020 ) . We fi nd widespread population that there were 11-12 population infections per diagnosed case. In Ontario, there were 15 population infections per diagnosed case. These gaps align with differences in testing across provinces (Alberta and Quebec, 27 and 22 per 1,000, respectively, vs. Ontario, 13 per 1,000). Meanwhile, British Columbia had the smallest fraction of undetected cases, despite conducting just 14 tests per 1,000 population. This discrepancy can likely be attributed to the fact that the scope of the outbreak was substantially more (7) report the baseline estimates, and Columns (2), (4), (6), and (8) report the estimates based on augmented models that include province and state fi xed effects. Heteroskedasticity robust 95% confi dence intervals are reported in parentheses. Source: Authors' calculations. the large numbers of individuals with some level of immunity to the virus. 1 A large body of research in economics is devoted to the issue of non-random sampling. See Blundell and Costa Dias (2002 ) ; Das, Newey, and Vella (2003 ) ; Heckman (1976 Heckman ( , 1979 ; Heckman, Lalonde, and Smith (1999 ) ; and Newey (2009 ) . Epidemiologists have also devoted considerable attention to the issue of sample representativeness (for a detailed discussion, see Davey Smith and Ebrahim 2013). 2 To improve the precision of the estimates, we include all Canadian provinces and US states to estimate the selection bias gradient. Once this gradient has been estimated, however, our estimates of underlying prevalence rely solely on the shares of positive cases across the four Canadian provinces we study. 3 There is an extended period over which individuals may test positive for COVID-19. Polymerase chain reaction (PCR) testing has identifi ed cases days before symptom onset and detected continued viral RNA presence more than three weeks after symptom onset ( Cai et al. 2020 ; Huang et al. 2020 ; Zhou et al. 2020 ). These positive cases often occur among individuals who are no longer symptomatic, and it is believed that they refl ect lingering viral material that no longer poses a risk of transmission. 4 British Columbia has a large number of missing observations because daily testing results were not always released. infection that exceeds offi cial reported cases by factors of 9 to 15 across provinces. Our fi ndings are comparable to recent prevalence estimates from the United States and countries in Western Europe. The estimated infection rates in Quebec are similar to those of the United Kingdom (2.7%) and several US states (Pennsylvania, 2.4%; Rhode Island, 2.4%; and Massachusetts, 3.4%). Meanwhile, the rates in Ontario are similar to those in Austria (1.1%), Denmark (1.1%), Vermont (1.4%), Virginia (1.4%), and Idaho (1.5%) in early April (see Benatia et al. 2020 ; Ferguson et al. 2020 ; Johndrow et al. 2020 ; Javan et al. 2020 ) . Our results are also consistent with recent evidence from serological testing across several US jurisdictions that shows widespread undetected infection by mid-April ( Bendavid et al. 2020 ; Conarck and Chang 2020 ; Goodman and Rothfeld 2020 ) . Our analysis provides a complement to existing methods used to estimate population infection rates. These approaches require either strong assumptions about unknown disease parameters or accurate measurement of COVID-related deaths, which may be undercounted over the course of the pandemic. Our estimation approach builds on standard econometric techniques. As high-frequency test data become more widely available at fi ner geographic units, this approach could be applied to estimate population infection rates at the city or district level. The current estimates depend on the accuracy of an extrapolation of the functional form relating the number of tests and the positive case rate to the large untested population. In ongoing work, we hope to refi ne the estimation procedure and explore the sensitivity of the results to various functional form assumptions. As physical distancing policies continue to be relaxed, it will be essential that policy-makers have access to timely data on infection rates. Given the potential for widespread undiagnosed infection, the expansion of randomized population-based PCR testing may play a key role in identifying localized outbreaks. Meanwhile, widespread implementation of serological testing will help identify Novel Coronavirus Infection: Clinical and Epidemiological Features Commercial Laboratory Seroprevalence Survey Data Pollution, Infectious Disease, and Mortality: Evidence from the Spanish Infl uenza Pandemic What Explains Cross-city Variation in Mortality during the 1918 Infl uenza Pandemic? Evidence from 440 U.S. Cities The Value of Health Insurance during a Crisis: Effects of Medicaid Implementation on Pandemic Infl uenza Mortality Miami-Dade Has Tens of Thousands of Missed Coronavirus Infections, UM Survey Finds Nonparametric Estimation of Sample Selection Models Epidemiological Characteristics of 2143 Pediatric Patients with 2019 Coronavirus Disease in China Impacts of Non-Pharmaceutical Interventions to Reduce COVID-19 Mortality and Healthcare Demand 1 in 5 New Yorkers May Have Had COVID-19, Antibody Tests Suggest The Effects of Outdoor Air Pollution Concentrations and Lockdowns on COVID-19 Infections in Wuhan and Other Provincial Capital in China Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report on 1014 Cases Identifi cation and Estimation of Undetected COVID-19 Cases Using Testing Data from Iceland Presumed Asymptomatic Carrier Transmission of COVID-19 Estimating CO-VID-19 Prevalence in the United States: A Sample Selection Model Approach COVID-19 Antibody Seroprevalence in Open Access Epidemiological Data and an Interactive Dashboard to Monitor the COVID-19 Outbreak in Canada Evaluation Methods for Non-Experimental Data A Case Series of Facilitates the Rapid Dissemination of Novel Coronavirus (SARS-CoV-2) Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing SARS-CoV-2 Infection in Children Estimating the COVID-19 Infection Rate: Anatomy of an Inference Problem The COVID Tracking Project Two-Step Series Estimation of Sample Selected Models Asymptomatic Cases in a Family Cluster with SARS-CoV-2 Infection Estimating Unobserved SARS-CoV-2 Infections in the United States Doctors and Nurses Say More People Are Dying of COVID-19 in the US than We Know The Incidence of COVID-19 Infection in Canada? New Survey Points to Over 100,000 Household Adjusted Age-Specifi c Case Fatality Rates during the CO-VID-19 Epidemic Estimation of SARS-CoV-2 Mortality during the Early Stages of an Epidemic: A Modelling Study in Hubei, China and Northern Italy Statistics Canada Estimates of the Severity of Coronavirus Disease 2019: A Model-Based Analysis Econometric Analysis of Cross Section and Panel Data The Common Structure of Statistical Models of Truncation, Sample Selection and Limited Dependent Variables and a Simple Estimator for Such Models Sample Selection Bias as a Specifi cation Error The Economics of Active Labor Market Programs Quebec Premier Says All Patients and Staff to Be Tested at Long-Term Care Homes Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China A Family Cluster of SARS-CoV-2 Infection Involving 11 Patients in Nanjing, China Probability of Current COVID-19 Outbreaks in All US Counties Estimating SARS-CoV-2 Positive Americans Using Deaths-Only Data Estimating_SARS-CoV-2-positive_Americans_using_ deaths-only_data Coronavirus: Ontario to Test All Long Term Care Residents, Staff for COVID-19 Death in New York City Are More than Double the Usual Total The Incubation Period of Coronavirus Disease 2019 (COVID-19) from Publicly Reported Confi rmed Cases: Estimation and Application Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia Substantial Undocumented Infection Infections Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China Exposure to Air Pollution and COVID-19 Mortality in the United States Evaluating the Accuracy of Different Respiratory Specimens in the Laboratory Diagnosis and Monitoring the Viral Shedding We thank seminar participants at McGill University, Université de Montréal, and École Polytechnique for valuable suggestions. We are especially grateful to Xavier d'Hautefoeuill, Tim Guinnane, Angelo Melino, Peter Tankov, and anonymous referees for detailed comments. This study was supported by funding from the Social Sciences and Humanities Research Council. The results are not sensitive to the inclusion of higher-order terms. Our baseline estimating equation does not include a constant, although we explore the robustness of the results to jurisdiction-specifi c intercepts. 7 Similar standard errors are found in models that allow for within-state/within-province serial correlation. 8 There is little guidance from theory about the functional form of relationship, and there are no individual-level survey data to shed light on who is tested. 9 To see why this is the case, let π < 1 denote the fi xed probability that a test is positive if an individual is sick, so that some fraction of sick individuals may not be detected by testing. In this case, the researcher observes s/n, but the actual share of positive cases among the tested sample is s n .Provided that the rate of false negatives is constant over time, the term π drops out of the fi rst difference Equation (4), so it will not affect the main estimates. 10 Figure 3 presents both all-age and aged-younger-than-70-years population infection rates.